Background: Worldwide highest number of new pulmonary tuberculosis (PTB) cases, was reported from India in 2012. Adverse treatment outcomes and emergence of drug resistance further complicated the prevailing scenario owing to increased duration, cost and toxicity associated with the treatment of drug-resistant cases. Hence to reinforce India's fight against TB, identification of the correlates of adverse treatment outcomes and drug resistance, seemed critical.
Introduction
Tuberculosis (TB) continues to be a major public health problem and is currently the second largest infectious cause of death worldwide. [1] As per World Health Organization's (WHO) estimate, in 2012, approximately 8.6 million people developed TB and 1.3 million died from it. [1] About 58% of these new infections were reported from Asian countries, with India being the largest contributor of incident TB infections in the world (176 per 100,000 population), accounting for 26% of the total global cases in 2012. [1] .
WHO-assisted Directly Observed Treatment-Short course (DOTS) program in India not only serves more than 100,000 patients per month but also holds the distinction of being the largest and fastest expanding TB control program in the world. [2] [3] [4] [5] However, despite the significant strides made by this program, annual incidence of TB in this country still hovers above two million cases, and on an average, two TB-related deaths are reckoned to occur in every three minutes. [4, 5] .
Since the anti-tubercular drugs (ATD) have become available, improper regimen, indiscriminate usage and less than optimal adherence have undermined the potential benefits -largely by facilitating the emergence of drug-resistant strains, particularly the multi-drug resistant (MDR) variety. [6, 7] MDR-TB strains are distinguished by their resistance to isoniazid (INH) and rifampicin (RIF), two most potent first line ATDs, but not necessarily to other ATDs. [8] Globally, an estimated 3.6% of new (450,000) and 20.2% of previously-treated TB cases were diagnosed with MDR-TB in 2012. [1] Expectedly, patients with prior exposure to anti-TB therapy turned out to be the ones more vulnerable to developing drug resistance, [9] but it was perturbing to note that even the newly diagnosed cases had considerable propensity of having MDR, with possible contributing factors being spontaneous mutation and transmission of resistant strains from others patients harboring MDR-TB. [10, 11] .
Rapid emergence of drug resistance, particularly MDR constitutes a major threat to TB control in India. [7, 12, 13 ] Data on drug resistance pattern prevailing in the community are scarcely available, and there exists considerable inconsistency among the published findings. [6, 10, 14] A 2012 country-level estimate by WHO reported India's burden of MDR-TB to be moderately high (about 2.2% of new TB cases and 15% of retreatment cases), [1] however, there was substantial heterogeneity across reviewed studies.
The impact of MDR-TB, in terms of disease containment efforts and economic burden, on the public health infrastructure of a developing nation like India is enormous. Some of the public health challenges associated with it are: expensive laboratory procedures for diagnosis, limited number and capacity of testing facilities, long duration of treatment regime, requirement of multiple expensive, less potent, more toxic and relatively less available second line anti-TB drugs, shortage of trained staff and facilities for treatment and proper monitoring of the infected. [1, 12, 13] .
The above shortcomings accompanying MDR-TB program become more glaring while addressing the problem of pulmonary TB (PTB) cases, owing to associated clinical severity. Constraints associated with the diagnosis and treatment of MDR-PTB thus call for efforts to identify the socio-demographic and clinical correlates of drug resistant PTB and poorer treatment outcomes. It is vital to take into consideration such predictors, especially the less resource intensive ones, in order to design and implement effective intervention strategies for minimizing the potential of emergence of resistant cases and improving treatment outcomes (e.g. reduction in number of relapses, defaulters and treatment-failures). In view of the above, a cross-sectional study was conducted to understand the interrelationship between diagnostic features (radiological and microscopic), patient type and drug resistance patterns among PTB patients.
Methodology
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Written informed consents were collected from each participant before the interview and sample collection. Subjects were free to decline participation without any consequences towards their treatments.
Recruitment
Current study was conducted in the out and in-patient departments of Chest Medicine in two tertiary care hospitals (the DOTS clinic of SSKM Hospital and Chest clinic of Calcutta National Medical College) of Kolkata, a populous city of eastern India. Consenting sputum-smear-positive PTB patients (according WHO criteria and standard guidelines), [1, 15] were recruited for the study during their first attendance between April 2010 and March 2013. Subjects were excluded from the analyses if they later turned out to be culture-negative for Mycobacterium, had infection with Mycobacterium other than M. tuberculosis or respective cultures got contaminated. As the parameter values regarding the variables of interest were not available in the study area, prior calculation of the required sample size was not possible. Hence we decided to recruit all the eligible cases identified during the study period.
Data Collection
Socio-demographic information such as age (,20/20-45/.45 years), gender (male/female), marital status (unmarried/married), socio-economic status (high/middle/low income group determined based on per capita monthly income, education and occupation of the head of the household using Kuppuswamy's Socio-Economic Status Scale) and district of residence (Kolkata/ 24 Parganas South/North) were collected through face-to-face interviews, whereas body mass index (Body weight(kg)/ Height 2 (mt)) and blood hemoglobin (gm/dl) levels were measured by trained medical/paramedical staff. Based on the clinical history of diagnosis and prior treatment outcomes (if any), recruited PTB cases were classified (patient types) into new/relapse/defaulter/ treatment failure according to WHO criteria. [1] .
Chest X-ray and Sputum-smear Examination
Chest radiographic results of the participants, as evaluated by clinicians, were categorized into minimal/moderately advanced/ far advanced/having cavities. [15, 16] As per the WHO and Government of India collaborative guidelines, grade of sputumsmear positivity was classified into scanty/single/double/triple positive status based on microscopic findings. [17] .
Laboratory testing
Morning sputum samples were collected from each patient and processed by digestion and decontamination using the N-acetyl-Lcysteine (NALC)/sodium hydroxide (NaOH) method. [7] The resuspended sediment from the decontaminated pellet was then used for Ziehl-Neelsen (ZN) staining, inoculation on LowensteinJensen (LJ) solid and Middlebrook 7H9 liquid media. [7, 18] .
Biochemical tests (niacin test, catalase test, nitrate reduction and aryl sulfatase) were next performed to identify M. tuberculosis among the Mycobacterial isolates. [13] The positive cultures were also subjected to extraction of genomic DNA following the phenolchloroform method. [19] Molecular confirmation was carried out by multiplex-PCR [20] for amplification of hsp 65, dnaj, is6110 genes specific to M. tuberculosis.
Detection of drug resistance pattern
For rapid detection of MDR isolates, multiple-allele-specific PCR (MAS-PCR) was conducted using allele-specific primers. [21] For detection of Isoniazid (INH), Rifampicin (RIF) or Ethambutol (EMB) resistance, amplifications of katG gene and promoter region of mabA-inhA, rpoB gene, embB gene were carried out, respectively. The amplified products were visualized in a 2.5% metaphor gel under a UV GEL DOC (BIO-RAD). Based on the results, participating TB cases were classified into those infected with MDR/Non-MDR two drug/Single drug resistant or susceptible strains of M. tuberculosis.
All the radiological (chest X-ray) and laboratory investigation results (sputum smear examination, MAS-PCR and biochemical tests) were duly double checked by a team of independent experts in the respective departments.
Data analyses
Descriptive analyses were done to understand the overall distribution (mean/proportion and corresponding 95% confidence intervals (CI)) of the patient characteristics along with drug resistance patterns. Further, stratified distributions of these characteristics across the strata of drug resistance were examined. Bivariate and multivariate logistic regression analyses [odds ratio (OR), adjusted odds ratio (AOR) and corresponding 95%CIs] were next conducted, respectively, to determine crude (OR) and adjusted (AOR: each predictor adjusted for all others) association between study variables. As the dependent variables (patient types, X-ray features and drug resistance patterns) had more than two categories, multinomial logistic regressions were used. [22] All statistical analyses were conducted using SAS version 9.3.
Results
Among the sputum samples collected from 458 recruited PTB cases, 35 (7.6%) got contaminated and 34 (7.4%) showed no growth. Biochemical tests and multiplex-PCR of the remaining 389 culture-positive isolates identified 350 samples positive for M. tuberculosis while rest 39 belonged to different Mycobacterium species. (Figure 1 Table 1) .
Distribution of the socio-demographic characteristics along with clinical, radiological and laboratory parameters across the strata of drug resistance pattern is presented in Table 2 . Results of bivariate and multivariate (each predictor adjusted for all others) regression analyses (to determine association between patient types and their physical/socio-demographic/microscopic/X-ray features) are presented in Table 3 . Patients with higher mean BMI had lower odds (reference: new infection) of being a relapse [AOR = 0.06(0.03- (Table 5 ).
Discussion
Among 350 adolescent and adult smear-confirmed PTB patients due to M. tuberculosis infection, who attended two tertiary care hospitals in Kolkata between 2010-13, 68.57% belonged to relapse (44.00%), defaulter (15.43%) or treatmentfailure (9.14%) categories, 64.00% had poorer X-ray features (moderately advanced = 37.71%, far advanced = 17.14% and cavities = 9.14%) and 12.29% were diagnosed with MDR-PTB. MDR-TB consisted 6.36% of total new infections cases, but 15% among the previously treated group. These findings Table 4 . Association of X-ray findings with physical, socio-demographic and microscopic features among PTB patients in tertiary care hospitals of Kolkata, India, 2010 (N = 350). probably serve as a grim reminder of the prevailing complex scenario of PTB in the largest metropolitan city of eastern India, which is not unlike rest of the country. [14, 23, 24] It is worth noting that the burden of MDR-PTB among newly infected [24] and previously treated cases [23] in most Indian states have consistently remained high during past two decades, and even more alarmingly, a recent report suggested a gradually increasing trend in MDR-PTB prevalence across the country. [14] In view of the above, our study findings convey that Kolkata is no exception. In this study, corroborating with prior researches, having higher BMI was negatively associated with being a relapse/defaulter/ treatment-failure case. [25, 26] Improved nutritional status, which can positively influence immunity and treatment outcome, could be cited as a possible explanation; however, such finding could also have been an artifact of reverse causation, as implicated by deterioration of general health among relapse/defaulter/treatment-failure cases. We believe, our results indicate the importance of providing nutritional improvement counseling/advices during the course of TB treatment.
Relapsed cases and defaulters were found to have, counterintuitively, higher hemoglobin level. However, this again might be explained by possible reverse causation resulting from discontinuation of ATD therapy following initial physiological improvement (thus increase in hemoglobin) with the therapy. Thus, proper adherence counseling of patients at the time of initiating ATD is profoundly recommended.
Female subjects, in our study, were more likely to default in treatment compared to males, contradicting findings from previous studies, conducted elsewhere. [25, 27, 28] We hypothesize that the socio-cultural norms prevailing in the study area might have led to either lower awareness/adherence regarding ATD among females or had resulted in an underrepresentation of females among attendees of tertiary healthcare centers with uncomplicated, new infections.
Higher age was associated positively with relapse, potentially owing to poorer treatment outcomes resulting from different biological (diminishing immune function with increasing age) and social issues (self-neglect and poor knowledge/perception among elderly populace) working independently or in tandem. [29] .
Although the employed multivariate model lacked sufficient statistical power, results of bivariate analyses suggested that poorer prognostic categories of sputum-smear and chest radiographic features were both associated with higher likelihood of being a relapse/treatment-failure case. Taking into account tubercular disease pathogenesis, these findings seem inherently plausible. In the current study, compared to the corresponding reference groups, females, elderly, unmarried and worse grades of sputumsmear were positively associated with poorer/more advanced chest-X-ray features, but higher BMI appeared to be a negative correlate of the same. Based on above, it is suggested that these socio-demographic and clinical parameters might well be taken into account while planning, designing and implementing preventive and curative components of the TB control program in this part of the country.
In this study higher age was found to be associated with higher odds of being MDR or non-MDR 2 drug resistant PTB cases, which highlighted the crucial role of poor awareness/perception, healthcare access/utilization and relatively lower social attention towards the elderly populace. [29] . Unmarried subjects also appeared to be more likely to be suffering from MDR or non-MDR 2 drug resistant PTB, compared to their married counterparts, and behavioral factors might be implicated behind this association. [30] .
In sync with our observation regarding treatment outcomes, higher BMI seemed to be also associated negatively with emergence of drug resistance among participating PTB cases.
In corroboration with prior findings, relapse/defaulters/treatment-failure cases were found to have higher propensity of being MDR and non-MDR 2 drug resistant cases of PTB. [17, 31, 32] .
Interestingly, it was observed that subjects with advanced radiological features had lower odds of having MDR or non-MDR 2 drug resistant PTB. Such observation points towards the possibility that cases with advanced radiological findings might be more likely to have been subjected to aggressive therapeutic and behavioral (counseling) interventions, often leading to improved treatment response and adherence, and therefore, lower likelihood of development of resistance.
Overall, the findings regarding resistance pattern seen in our study participants, make us infer that appropriate and intensive counseling of ATD initiates should be emphasized upon, in order to improve adherence to the treatment protocol among the PTB cases, and thereby reduce emergence of resistance.
Our study suffered from some major limitations. Due to the cross-sectional design, causal interpretations of the observed associations were not possible and temporal ambiguity affected inferences due to the potential for reverse causation. As the study was conducted in two tertiary care hospitals of Kolkata, often receiving referred (and relatively severe) cases from lower level healthcare providers, we might have overestimated the overall burden and some severity characteristics. Hence, extrapolation of the results beyond the study sample is not recommended, as lack of external validity may be suspected.
Despite of these limitations, we believe, our study findings have been bolstered by employing advanced laboratory techniques like MAS-PCR and sophisticated statistical analyses. The results of this study may help concerned policy makers to gain important insights into the aspects and correlates of drug resistance and treatment outcomes of PTB cases in this part of India, where similar efforts have been scanty till date.
Conclusions
Implementation of targeted intervention and appropriate counseling seem to be an urgent requirement in order to improve the efficacy of various TB control approaches for specific demographics like females, elderly and unmarried in Kolkata.
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